PDCO
60
13
HON
62
2
KMI
48
-3
MSI
57
5
APH
58
3
SO
60
3
SWN
67
4
THC
70
2
KMB
44
4
UPS
48
3
CL
61
3
SRE
54
-3
CME
65
3
MPC
52
13
SYY
62
2
AAL
42
7
BAC
42
3
IPG
61
11
ZION
53
4
AFL
63
3
PDCO
60
13
HON
62
2
KMI
48
-3
MSI
57
5
APH
58
3
SO
60
3
SWN
67
4
THC
70
2
KMB
44
4
UPS
48
3
CL
61
3
SRE
54
-3
CME
65
3
MPC
52
13
SYY
62
2
AAL
42
7
BAC
42
3
IPG
61
11
ZION
53
4
AFL
63
3
Financhill
Back

BridgeBio Pharma Stock Predictions

Election Shock on August 19th?

Click here now to see the evidence I've gathered.
Sell
22

BBIO
BridgeBio Pharma

Last Price:
25.45
Seasonality Move:
33.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 31.4% based on the past 4 years of stock performance.
  • BridgeBio Pharma has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $25.09. The Score for BBIO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 31.4% based on the past 4 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
22
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
44.32
52-Week Low:
12.75

Prediction Charts

Market Cap:
4.41B
Price in USD:
25.09
Volume:
1.91M
Beta:
1.03

Technical Analysis

SMA50:
30.35
SMA100:
33.29
SMA200:
30.63
52-Wk Change:
58%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 25.09 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-3 29.01 29.23 29.33 28.28
Apr-4 29.47 28.16 29.65 28.11
Apr-5 27.90 28.10 28.77 27.73
Apr-8 28.39 28.27 28.73 27.86
Apr-9 28.27 28.43 28.65 27.91
Apr-10 27.29 27.33 27.51 26.73
Apr-11 27.70 28.38 28.76 26.86
Apr-12 27.92 26.83 28.13 26.37
Apr-15 26.68 25.78 26.70 25.70
Apr-16 25.39 25.24 25.91 25.20
Apr-17 25.54 24.98 25.66 24.80
Apr-18 24.85 24.98 25.52 24.77
Apr-19 24.88 24.75 25.36 24.27
Apr-22 24.99 25.09 25.52 24.14

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.16 per share, an increase this year of $0.46 per share, and an increase next year of $0.54 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.